Victory Capital Management Inc. Trims Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Victory Capital Management Inc. cut its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 1.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 141,145 shares of the medical instruments supplier’s stock after selling 1,390 shares during the quarter. Victory Capital Management Inc. owned approximately 0.58% of ICU Medical worth $21,901,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of ICUI. State Street Corp boosted its holdings in ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after buying an additional 77,506 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after acquiring an additional 48,106 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of ICU Medical by 1.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier’s stock valued at $47,196,000 after acquiring an additional 3,048 shares during the period. Principal Financial Group Inc. increased its stake in shares of ICU Medical by 4.1% in the 4th quarter. Principal Financial Group Inc. now owns 132,099 shares of the medical instruments supplier’s stock valued at $20,498,000 after purchasing an additional 5,162 shares in the last quarter. Finally, FMR LLC raised its holdings in ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock worth $18,968,000 after purchasing an additional 100,345 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on the company. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. StockNews.com cut shares of ICU Medical from a “buy” rating to a “hold” rating in a research note on Monday. KeyCorp boosted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Finally, Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a report on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $199.67.

Insider Activity at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 6.70% of the stock is owned by corporate insiders.

ICU Medical Stock Performance

NASDAQ ICUI opened at $138.99 on Wednesday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock’s 50 day simple moving average is $158.23 and its 200-day simple moving average is $165.42. The company has a market cap of $3.41 billion, a PE ratio of -30.41 and a beta of 0.73. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.